Triple-mutant AML: too clever by HLF?

Blood. 2019 Jul 18;134(3):222-224. doi: 10.1182/blood.2019001533.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fibrinogen
  • Humans
  • Leukemia, Myeloid, Acute*
  • Nuclear Proteins*
  • Stem Cells
  • fms-Like Tyrosine Kinase 3

Substances

  • Nuclear Proteins
  • Fibrinogen
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3